Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R van Eekelen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Human Reproduction (Oxford, England)|January 19, 2021
Reply: Cost-effectiveness analyses in ART consumerism require transparency, simplicity and reproducibilityR van Eekelen, M van Wely,
ESMO Open|March 18, 2026
Cost-effectiveness of switching to S-1 after fluoropyrimidine-induced hand-foot syndrome or cardiovascular toxicity in the treatment of metastatic colorectal cancerR van Eekelen, C J A Punt, J J M Kwakman, et al.
Human Reproduction (Oxford, England)|February 22, 2021
Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertilityR van Eekelen, R Wang, N A Danhof, et al.
Human Reproduction (Oxford, England)|September 3, 2020
Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?R van Eekelen, M J Eijkemans, M Mochtar, et al.
Human Reproduction (Oxford, England)|October 26, 2018
External validation of a dynamic prediction model for repeated predictions of natural conception over timeR van Eekelen, D J McLernon, M van Wely, et al.
Human Reproduction (Oxford, England)|June 14, 2019
IVF for unexplained subfertility; whom should we treat?R van Eekelen, N van Geloven, M van Wely, et al.
Reproductive Biomedicine Online|April 15, 2019
Follicle stimulating hormone or clomiphene citrate in intrauterine insemination with ovarian stimulation for unexplained subfertility: a role for treatment selection markers?N A Danhof, R van Eekelen, S Repping, et al.
Human Reproduction Open|January 15, 2020
Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysisN A Danhof, R van Eekelen, S Repping, et al.
Human Reproduction Open|February 18, 2021
Does the effectiveness of IUI in couples with unexplained subfertility depend on their prognosis of natural conception? A replication of the H2Oil studyR van Eekelen, K Rosielle, N van Welie, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 20, 2026
Influence of incubator type on embryo development and clinical outcomes: A retrospective cohort study comparing time-lapse benchtop incubators versus big box incubatorsD C Kieslinger, S C M Scholtenhave, E H Kostelijk, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Human Reproduction (Oxford, England)|January 19, 2021
Reply: Cost-effectiveness analyses in ART consumerism require transparency, simplicity and reproducibilityR van Eekelen, M van Wely,
ESMO Open|March 18, 2026
Cost-effectiveness of switching to S-1 after fluoropyrimidine-induced hand-foot syndrome or cardiovascular toxicity in the treatment of metastatic colorectal cancerR van Eekelen, C J A Punt, J J M Kwakman, et al.
Human Reproduction (Oxford, England)|February 22, 2021
Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertilityR van Eekelen, R Wang, N A Danhof, et al.
Human Reproduction (Oxford, England)|September 3, 2020
Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?R van Eekelen, M J Eijkemans, M Mochtar, et al.
Human Reproduction (Oxford, England)|October 26, 2018
External validation of a dynamic prediction model for repeated predictions of natural conception over timeR van Eekelen, D J McLernon, M van Wely, et al.
Human Reproduction (Oxford, England)|June 14, 2019
IVF for unexplained subfertility; whom should we treat?R van Eekelen, N van Geloven, M van Wely, et al.
Reproductive Biomedicine Online|April 15, 2019
Follicle stimulating hormone or clomiphene citrate in intrauterine insemination with ovarian stimulation for unexplained subfertility: a role for treatment selection markers?N A Danhof, R van Eekelen, S Repping, et al.
Human Reproduction Open|January 15, 2020
Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysisN A Danhof, R van Eekelen, S Repping, et al.
Human Reproduction Open|February 18, 2021
Does the effectiveness of IUI in couples with unexplained subfertility depend on their prognosis of natural conception? A replication of the H2Oil studyR van Eekelen, K Rosielle, N van Welie, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 20, 2026
Influence of incubator type on embryo development and clinical outcomes: A retrospective cohort study comparing time-lapse benchtop incubators versus big box incubatorsD C Kieslinger, S C M Scholtenhave, E H Kostelijk, et al.
Pageof 3